We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

GoodRx Holdings Inc (GDRX) USD0.0001

Sell:$7.71 Buy:$7.72 Change: $0.32 (3.99%)
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
Change: $0.32 (3.99%)
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
Change: $0.32 (3.99%)
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.

Contact details

2701 Olympic Boulevard, Suite 990
United States
+ ()

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$3.00 billion
Shares in issue:
375.21 million
Health Care Technology
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Trevor Bezdek
    Chairman of the Board, Co-Founder
  • Scott Wagner
    Interim Chief Executive Officer
  • Douglas Hirsch
    Co-Founder, Chief Mission Officer, Director
  • Karsten Voermann
    Chief Financial Officer
  • Bansi Nagji
    President - Healthcare
  • Raj Beri
    Chief Operating Officer
  • Andrew Slutsky
    Senior Vice President - Strategic Marketing Innovation , Chief Marketing Officer
  • Romin Nabiey
    Chief Accounting Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.